What is the recommended workup and treatment for an adult with dyspepsia, including assessment of alarm symptoms, age‑based H. pylori testing, and appropriate pharmacologic therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Dyspepsia in Adults

For patients under 55 years without alarm symptoms, use non-invasive H. pylori testing ("test and treat") followed by PPI therapy if negative or symptoms persist; for patients ≥55 years or any age with alarm features, proceed directly to endoscopy. 1

Initial Risk Stratification by Age and Alarm Features

Patients ≥55 Years with New-Onset Dyspepsia

  • Proceed directly to esophagogastroduodenoscopy (EGD) regardless of alarm symptoms because upper gastrointestinal malignancy incidence increases substantially after age 55, making direct visualization and tissue sampling essential rather than optional. 1, 2
  • The age cutoff is critical: approximately 70% of early gastric cancers present with uncomplicated dyspepsia without alarm features like anemia, dysphagia, or weight loss. 2
  • Endoscopy should be preferred over upper gastrointestinal radiography because it has greater diagnostic accuracy and allows biopsy specimens for H. pylori testing. 1, 3

Urgent Endoscopy (Within 2 Weeks) Required For:

  • Age ≥55 years with dyspepsia plus weight loss 1
  • Age >40 years from high gastric cancer risk areas or with family history of gastro-esophageal cancer 1
  • Any age with alarm features: progressive dysphagia, recurrent vomiting, evidence of gastrointestinal bleeding, palpable abdominal mass 1

Non-Urgent Endoscopy Considered For:

  • Age ≥55 years with treatment-resistant dyspepsia 1
  • Age ≥55 years with raised platelet count or nausea/vomiting 1

Patients <55 Years Without Alarm Features

  • Use the "test and treat" approach for H. pylori as it is equally effective and more cost-efficient than prompt endoscopy. 4
  • This recommendation is cost-effective and includes patients with uncomplicated duodenal ulcer disease. 1

H. Pylori Testing Strategy

Optimal Non-Invasive Tests (Choose One):

  • 13C-urea breath test (preferred) 1, 4
  • Stool antigen test (alternative) 1, 4
  • Do NOT use IgG or IgM antibody serology as primary diagnostic method due to lower specificity and cost-effectiveness. 4

If H. Pylori Positive:

  • Provide eradication therapy using triple therapy: PPI + amoxicillin + clarithromycin for 14 days. 4
  • Eradication provides modest but significant benefit in dyspepsia, leads to long-term symptom improvement, and reduces risk of peptic ulcer disease, atrophic gastritis, and gastric cancer. 4
  • Confirmation testing after eradication is only needed in patients with increased risk of gastric cancer (family history, high-risk ethnicity), not routinely in low-risk patients. 1, 4

If H. Pylori Negative or Symptoms Persist After Eradication:

  • Offer empirical acid suppression with PPI for 4-8 weeks. 1, 4
  • PPIs are the drug class of choice for acid suppression with strong evidence in dyspepsia. 1
  • Use the lowest effective PPI dose, taken 30-60 minutes before meals. 4

Baseline Laboratory Investigations

  • Full blood count mandatory in patients aged ≥55 years 1
  • Coeliac serology in all patients with overlapping IBS-type symptoms 1
  • Urgent abdominal CT scan for patients ≥60 years with abdominal pain and weight loss to exclude pancreatic cancer. 1

Endoscopy Technique Requirements (When Performed)

  • Obtain biopsy specimens for H. pylori at time of endoscopy using rapid urease test and/or culture/sensitivity/histology. 1
  • For gastric lesions, obtain at least 6 samples using standard biopsy forceps to achieve diagnostic accuracy approaching 100%. 2
  • Stop PPIs before first endoscopy as they can mask endoscopic findings, delay diagnosis, or result in misdiagnosis by "healing" malignant ulcers. 2

Management After Failed Empirical Therapy

If Symptoms Persist Despite H. Pylori Eradication and PPI Trial:

  • Consider endoscopy in younger patients (<55 years) but recognize this should be evaluated in the wider context of reassessing symptoms and diagnosis. 1
  • Endoscopy may reassure some young patients but evidence suggests this is not the case in those who are most anxious. 1
  • The yield of endoscopy is low in young patients without alarm features who have failed empirical therapy. 1

Alternative Therapies if PPI Ineffective:

  • Tricyclic antidepressants or prokinetic therapies can be tried. 5
  • Regular aerobic exercise is recommended for all patients with functional dyspepsia. 1

Critical Pitfalls to Avoid

  • Do NOT dismiss symptoms as functional dyspepsia without proper investigation in patients ≥55 years with new-onset symptoms, as this age cutoff exists specifically because malignancy risk increases substantially. 2
  • Do NOT rely on absence of alarm symptoms to defer endoscopy in elderly patients, as this approach causes localized disease to be overlooked. 2
  • Do NOT use CT imaging as substitute for endoscopy in initial evaluation, as CT may miss gastric masses due to gastric underdistension. 2, 3
  • The value of alarm symptoms in younger patients is controversial and not very useful in diagnosing upper gastrointestinal malignancy, but they remain important in older patients. 1

Patient Education and Follow-Up

  • Establish an effective and empathic doctor-patient relationship as this may reduce healthcare utilization and improve quality of life. 1
  • Explain FD as a disorder of gut-brain interaction, including how the gut-brain axis is impacted by diet, stress, cognitive, behavioral and emotional responses to symptoms, and postinfective changes. 1
  • Screen for potential aetiological triggers including previous acute enteric infection (present in ~10% of patients). 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of New-Onset Dyspepsia in Elderly Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach to Upper GI Symptoms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of H. pylori Infection in Patients with Dyspepsia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

ACG and CAG Clinical Guideline: Management of Dyspepsia.

The American journal of gastroenterology, 2017

Related Questions

What are other medication options for a patient with dyspepsia, particularly those with postprandial pain and fullness, and a possible history of Helicobacter pylori infection?
What is the best way to test an elderly female patient with achalasia, chronic dyspepsia, and a Percutaneous Endoscopic Gastrostomy (PEG) tube, who is taking Prevacid (Lansoprazole) 30mg twice a day, for H. pylori infection besides an Esophagogastroduodenoscopy (EGD) and biopsy, and will she need to stop her Proton Pump Inhibitor (PPI) beforehand?
What is an inappropriate indication for upper gastrointestinal endoscopy among the given options?
What is the recommended work‑up and treatment for an adult presenting with dyspepsia?
What is the protocol for Helicobacter pylori (H. pylori) eradication and acid suppression therapeutics, including proton pump inhibitor (PPI) dosing, frequency, and duration, as well as step-up and step-down treatment approaches for patients with dyspepsia?
In a 35‑year‑old woman with no known medical problems who has a fasting plasma glucose of 6.4 mmol/L, total cholesterol of 6.9 mmol/L, triglycerides of 2.0 mmol/L, and LDL‑cholesterol of 4.24 mmol/L, what is the appropriate management?
In an adult postoperative intensive care unit patient after exploratory laparotomy who is being treated for severe sepsis with meropenem, teicoplanin, polymyxin B, metronidazole, and ofloxacin and has hypernatremia and severe hypokalemia, what is the appropriate venous thrombo‑embolism prophylaxis strategy?
What is the appropriate treatment for a pregnant woman with severe, intractable hyperemesis gravidarum?
What anteroposterior (AP) spinal canal diameter is considered abnormal for the lumbar, cervical, and thoracic spine?
What is the appropriate outpatient management for an adult patient presenting with dyspepsia without alarm features?
A patient has urinary symptoms of cystitis with pyuria (~10 white blood cells per high‑power field) but a sterile urine culture; what are the possible causes and how should this be evaluated and managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.